CanSino Biologics Inc. (SHA:688185)

CanSino Biologics Statistics

Total Valuation

SHA:688185 has a market cap or net worth of CNY 11.60 billion. The enterprise value is 10.30 billion.

Market Cap	11.60B
Enterprise Value	10.30B

Important Dates

The next estimated earnings date is Thursday, March 5, 2026.

Earnings Date	Mar 5, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	114.37M
Shares Outstanding	n/a
Shares Change (YoY)	-1.66%
Shares Change (QoQ)	-40.81%
Owned by Insiders (%)	31.39%
Owned by Institutions (%)	7.04%
Float	159.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	50.91
PS Ratio	11.94
PB Ratio	2.35
P/TBV Ratio	2.45
P/FCF Ratio	n/a
P/OCF Ratio	75.52
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-72.49
EV / Sales	11.09
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-65.75

Financial Position

The company has a current ratio of 3.62, with a Debt / Equity ratio of 0.29.

Current Ratio	3.62
Quick Ratio	3.24
Debt / Equity	0.29
Debt / EBITDA	n/a
Debt / FCF	-9.10
Interest Coverage	-4.67

Financial Efficiency

Return on equity (ROE) is -2.84% and return on invested capital (ROIC) is -6.46%.

Return on Equity (ROE)	-2.84%
Return on Assets (ROA)	-1.87%
Return on Invested Capital (ROIC)	-6.46%
Return on Capital Employed (ROCE)	-3.68%
Weighted Average Cost of Capital (WACC)	10.51%
Revenue Per Employee	879,483
Profits Per Employee	-128,538
Employee Count	1,105
Asset Turnover	0.13
Inventory Turnover	0.71

Taxes

Income Tax	-4.98M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.49% in the last 52 weeks. The beta is 1.31, so SHA:688185's price volatility has been higher than the market average.

Beta (5Y)	1.31
52-Week Price Change	+6.49%
50-Day Moving Average	66.57
200-Day Moving Average	69.76
Relative Strength Index (RSI)	62.69
Average Volume (20 Days)	2,770,204

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:688185 had revenue of CNY 971.83 million and -142.03 million in losses. Loss per share was -0.58.

Revenue	971.83M
Gross Profit	721.50M
Operating Income	-228.65M
Pretax Income	-147.01M
Net Income	-142.03M
EBITDA	-84.46M
EBIT	-228.65M
Loss Per Share	-0.58

Balance Sheet

The company has 2.79 billion in cash and 1.43 billion in debt, with a net cash position of 1.37 billion.

Cash & Cash Equivalents	2.79B
Total Debt	1.43B
Net Cash	1.37B
Net Cash Per Share	n/a
Equity (Book Value)	4.93B
Book Value Per Share	27.01
Working Capital	2.85B

Cash Flow

In the last 12 months, operating cash flow was 153.62 million and capital expenditures -310.23 million, giving a free cash flow of -156.61 million.

Operating Cash Flow	153.62M
Capital Expenditures	-310.23M
Free Cash Flow	-156.61M
FCF Per Share	n/a

Margins

Gross margin is 74.24%, with operating and profit margins of -23.53% and -14.62%.

Gross Margin	74.24%
Operating Margin	-23.53%
Pretax Margin	-15.13%
Profit Margin	-14.62%
EBITDA Margin	-8.69%
EBIT Margin	-23.53%
FCF Margin	n/a

Dividends & Yields

SHA:688185 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.66%
Shareholder Yield	1.66%
Earnings Yield	-1.22%
FCF Yield	-1.35%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SHA:688185 has an Altman Z-Score of 3.12 and a Piotroski F-Score of 5.

Altman Z-Score	3.12
Piotroski F-Score	5